A graduate of the University of Vienna (Austria), he wrote his thesis on thrombolysis in acute myocardial infarction and trained in internal medicine, cardiology and intensive care at the university clinics in Freiburg, Germany. During his Post-Doc at the Brigham and Women´s Hospital (Harvard Medical School) he studied animal models of the Long-QT-Syndrome and gene transfer using (adeno-)viral vectors to ameliorate the phenotype. His research interest are translational, creating the first human transgenic rabbits models of the Long- and the Short-QT Syndrome, aimed at understanding arrhythmogenesis and triggering and influencing factors such as hormones. He obtained a PhD at the University of Maastricht, and a Master in Health Business Administration. Clinically his focus is interventional cardiology, electrophysiology and intensive care.
